Docusate Sodium

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	50804-862	50804-862-25	D	Discontinued by firm		2026-10-05

Adverse event summaries are temporarily unavailable. Other product information remains available.

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50804-862-25	EA - Each	50804-862	dacffe96-d3cc-4f77-9a06-810153e8d445	1	2023-02-06

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50804-862	DOCUSATE SODIUM CAPSULE [GOOD SENSE (GEISS, DESTIN & DUNN, INC.)]	4	Legacy NDC	20240404_d729ceac-2eef-40c0-bb1a-f8d80290c60f.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50804-862-25	50804086225	25 CAPSULE in 1 BOTTLE, PLASTIC (50804-862-25)	25 capsule	2021-05-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	PD-Rx Pharmaceuticals, Inc.	2025-10-01	HUMAN OTC DRUG LABEL	7
Drug Facts	Good Sense (Geiss, Destin & Dunn, Inc.)	2025-08-12	HUMAN OTC DRUG LABEL	5